Medical Microbiology and Immunology

, Volume 200, Issue 3, pp 155–159 | Cite as

Significant increase in travel-associated dengue fever in Germany

Original Investigation

Abstract

Increasing numbers of dengue fever (DF) cases reflect the increasing travel mobility together with the expanding geographical distribution of the vector Aedes aegypti. Compared with earlier surveys in Germany, higher incidences occur and correlate well with ongoing outbreaks. Therefore, we investigated 767 serum samples from 594 returning travellers with suspected DF between 2005 and 2010, which where sent from different hospitals in the drainage area Frankfurt/Main. Established diagnostic assays were ELISA, immunofluorescence and chromatographic tests. We obtained 112 dengue-seropositive serum samples from totally 60 patients: the detection rate was 10.1% (60 out of 594). A significant increase was found in 2010. Most patients were aged between 40 and 49, and indirect immunofluorescence technique indicated mainly DF serotype 2. Actual data reveal a significant rise in imported DF cases in 2010 according to an increasing risk to acquire DF virus infection. Nevertheless, dengue haemorrhagic fever and dengue shock syndrome are still rare in travellers, but those with a history of dengue should be tested for DF serotypes and advised to protect themselves well from mosquitoes when travelling to endemic areas.

Keywords

Travel medicine Increasing dengue fever Dengue fever diagnostics 

Notes

Acknowledgments

I would like to thank H. W. Doerr for his great support and all MTAs at the serological laboratory for their excellent technical assistance.

Conflict of interest

The author declares no conflict of interest.

References

  1. 1.
    Schmitz H, Emmerich P, ter Meulen J (1996) Imported tropical virus infections in Germany. Arch Virol Suppl 11:67–74PubMedGoogle Scholar
  2. 2.
    Robert-Koch-Institut (RKI) (2010) Epidemiologisches Bulletin No 45, Berlin, Germany, p 452Google Scholar
  3. 3.
    Jänisch T, Preiser W, Berger A, Niedrig M, Mikulicz U, Thoma B, Doerr HW (1997) Emerging viral pathogens in long-term expatriates (II): dengue virus. Trop Med Inter Health. 2:934–940CrossRefGoogle Scholar
  4. 4.
    Stephan C, Allwinn R, Brodt H-R, Krupp B, Preiser W, Just-Nübling G (2002) Epidemiology and clinical manifestations in travel-acquired dengue infection. Infection 30:225–228PubMedCrossRefGoogle Scholar
  5. 5.
    Gibbons RV, Vaughn DW (2002) Dengue: an escalating problem. BMJ 324:1563–1566PubMedCrossRefGoogle Scholar
  6. 6.
    Doerr HW, Allwinn R, Preiser W (2000) Dengue fever. In:Licker MD (ed) Year book of science and technology. Professional Book Group. McGraw Hill, Inc., NY, pp 109–112Google Scholar
  7. 7.
    Schmidt AC (2010) Response to dengue fever—the good, the bad, and the ugly? N Engl J Med 363:484–487PubMedCrossRefGoogle Scholar
  8. 8.
    Monath TP, Heinz FX (1996) Flaviviruses. In: Fields BN 3rd, Knipe DM, Howley PM (eds) Fields virology. Lippincott-Raven Publ, Philadelphia, pp 961–1034Google Scholar
  9. 9.
    Gubler DJ (2002) Epidemic dengue/hemorrhagic fever as a public health, social and economic problem in the 21st century. Trends Microbiol 10:100–103PubMedCrossRefGoogle Scholar
  10. 10.
    Dejnirattisai W, Jumnainsong A, Onsirisakul N, Fitton P, Vasanawathana S, Limpitikul W, Puttikhunt C, Edwards C, Duangchinda T, Supasa S, Chawansuntati K, Malasit P, Mongkolsapaya J, Screaton G (2010) Cross-reacting antibodies enhance dengue virus infection in humans. Science 328:745–748PubMedCrossRefGoogle Scholar
  11. 11.
    Halstead SB (1988) Pathogenesis of dengue: challenges to molecular biology. Science 239:476–481PubMedCrossRefGoogle Scholar
  12. 12.
    Lawn SD, Tiley R, Lloyd G, Finlayson C, Tolley H, Newman P, Rice P, Harrison TS (2003) Dengue hemorrhagic fever with fulminate hepatic failure in an immigrant returning to Bangladesh. Clin Infect Dis 37:e1–e4PubMedCrossRefGoogle Scholar
  13. 13.
    Cobelens FG, Groen J, Osterhaus AD, Leentvaar-Kuipers A, Wertheim-van Dillen PM, Kager PA (2002) Incidence and risk factors of probable dengue virus infection among Dutch travellers to Asia. Trop Med Int Health 7:331–338PubMedCrossRefGoogle Scholar
  14. 14.
    O’Brien DP, Leder K, Matchett E, Brown GV, Torresi J (2006) Illness in returned travellers and immigrants/refugees: the 6-year experience of two Australian infectious diseases units. J Travel Med 13:145PubMedCrossRefGoogle Scholar
  15. 15.
    Wilder-Smith A, Brown GV, Torresi J (2001) Fever in returned travellers: review of hospital admissions for a 3-year period. Clin Infect Dis 33:603–609CrossRefGoogle Scholar
  16. 16.
    Allwinn R, Hofknecht N, Doerr HW (2008) Dengue in travellers is still underestimated. Intervirology 13(51):96–100CrossRefGoogle Scholar
  17. 17.
    Wichmann O, Jelinek T (2004) Dengue in travelers: a review. J Travel Med 11(3):161–170PubMedCrossRefGoogle Scholar
  18. 18.
    Schmidt-Chanasit J, Haditsch M, Schoneberg I, Gunther S, Stark K, Frank C (2010) Dengue virus infection in a traveller returning from Croatia to Germany. Euro Surveill 15(40):19677Google Scholar
  19. 19.
    Rovida F, Percivalle E, Campanini G, Piralla A, Novati S, Muscatello A, Baldanti F (2011) Viremic Dengue virus infections in travellers: potential for local outbreak in Northern Italy. J Clin Virol 50:76–79Google Scholar
  20. 20.
    La Ruche G, Souares Y, Armengaud A, Peloux-Petiot F, Delaunay P, Despres P, Lenglet A, Jourdain F, Leparc-Goffart I, Charlet F, Ollier L, Mantey K, Mollet T, Fournier J, Torrents R, Leitmeyer K, Hilairet P, Zeller H, Van Bortel W, Dejour-Salamanca D, Grandadam M, Gastellu-Etchegorry M (2010) First two autochthonous dengue virus infections in metropolitan France, September 2010. Euro Surveill Sep 30:15(39)Google Scholar
  21. 21.
    Bueno Marí R, Jiménez Peydró R (2010) Could malaria and dengue reappear in Spain? Gac Sanit; 24:347–353PubMedCrossRefGoogle Scholar
  22. 22.
    Rosen L (1986) Dengue in Greece in 1927 and 1928 and the pathogenesis of Dengue haemorrhagic fever: new data and a different conclusion. Am J Trop Med Hyg 35:642–653PubMedGoogle Scholar
  23. 23.
    Allwinn R, Doerr HW, Emmerich P, Schmitz H, Preiser W (2002) Cross-reactivity in flavivirus serology: new implications of an old finding? Med Microbiol Immunol 190:199–202PubMedCrossRefGoogle Scholar
  24. 24.
    Dobler G, Jelinek T, Frosner G, Nothdurft HD, Löscher T (1997) Cross reactions of patients with acute dengue fever to tick-borne encephalitis. Wiener Med Wochenschr 147(19–20):463–464Google Scholar
  25. 25.
    Wilder-Smith A, Tambyah PA (2007) Severe dengue virus infection in travelers. J Infect Dis 15(95):1081–1083CrossRefGoogle Scholar
  26. 26.
    Shu PY, Yang CF, Kao JF, Su CL, Lin CC, Yang WC, Shih H, Yang SY, Wu PF, Wu HS, Huang JH (2009) Application of the dengue virus NS1 antigen rapid test for on-site detection of imported dengue cases at airports. Clin Vaccine Immunol 16:589–591PubMedCrossRefGoogle Scholar
  27. 27.
    Allwinn R, Schieferstein C, Klauke S, Doerr HW (1999) Rapid diagnosis of primary dengue fever by the immunochromatographic test and by electron microscopy—a case report. Infection 27:365–367PubMedCrossRefGoogle Scholar
  28. 28.
    Wang SM, Sekaran SD (2010) Early diagnosis of Dengue infection using a commercial Dengue Duo rapid test kit for the detection of NS1, IGM, and IGG. Am J Trop Med Hyg 83(3):690–695PubMedCrossRefGoogle Scholar
  29. 29.
    Guzman MG, Jaenisch T, Gaczkowski R, Ty Hang VT, Sekaran SD, Kroeger A, Vazquez S, Ruiz D, Martinez E, Mercado JC, Balmaseda A, Harris E, Dimano E, Leano PS, Yoksan S, Villegas E, Benduzu H, Villalobos I, Farrar J, Simmons CP (2010) Multi-country evaluation of the sensitivity and specificity of two commercially-available NS1 ELISA assays for dengue diagnosis. PLoS Negl Trop Dis 31:4(8): e811Google Scholar
  30. 30.
    Van Panhuis WG, Gibbons RV, Endy TP, Rothman AL, Srikiatkhachorn A, Nisalak A, Burke DS, Cummings DAT (2010) Inferring the serotype associated with dengue virus infections on the basis of pre‐ and postinfection neutralizing antibody titers. J Infect Dis 202:1002–1010PubMedCrossRefGoogle Scholar
  31. 31.
    Sánchez-Seco MP, Rosario D, Hernández L, Domingo C, Valdés K, Guzmán MG, Tenorio A (2006) Detection and subtyping of dengue 1–4 and yellow fever viruses by means of a multiplex RT-nested-PCR using degenerated primers. Trop Med Int Health 11:1432–1441PubMedCrossRefGoogle Scholar
  32. 32.
    Huhtamo E, Vuorinen S, Uzcátequi NY, Vapalathi O, Haapasalo H, Lumio J (2006) Fatal dengue virus infection in a Finnish traveller. J Clin Virol 37(4):323–326PubMedCrossRefGoogle Scholar
  33. 33.
    Deen J (2004) The challenge of dengue vaccine development and introduction. Trop Med Int Health Volume 9(1):1–3CrossRefGoogle Scholar
  34. 34.
    Trent D, Shin J, Hombach J, Knezevic I, Minor P et al (2010) WHO Working Group on technical specifications for manufacture and evaluation of dengue vaccines, Geneva, Switzerland, 11–12 May 2009. Vaccine 28:8246–8255Google Scholar
  35. 35.
    Block OK, Rodrigo WW, Quinn M, Jin X, Rose RC, Schlesinger JJ (2010) A tetravalent recombinant dengue domain III protein vaccine stimulates neutralizing and enhancing antibodies in mice. Vaccine 28:8085–8094Google Scholar
  36. 36.
    Poo J, Galan F, Forrat R, Zambrano B, Lang J, Dayan GH (2010) Live-attenuated Tetravalent Dengue Vaccine in Dengue-naïve Children, Adolescents, and Adults in Mexico City: randomized Controlled Phase 1 Trial of Safety and Immunogenicity. Pediatr Infect Dis J Oct 28. [Epub ahead of print] PMID:21042231Google Scholar

Copyright information

© Springer-Verlag 2011

Authors and Affiliations

  1. 1.Institute of Medical VirologyUniversity Hospital Frankfurt/MainFrankfurt/MainGermany

Personalised recommendations